Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2019

View Archived Issues

Indirect targeting can affect serine production

Thai vaccine works better in South Africa

Targeting genes while avoiding their homologues can fix CGD

Lymphocytes check brain's privilege

NR4A1AS lncRNA regulates NR4A1 expression promoting colorectal cancer tumor growth and metastasis

DG-12P1 identified as first AI-discovered therapeutic candidate

Inflazome begins first-in-human study of IZD-334 for CAPS

New phase I trial of IGM-2323 enrolling patients with relapsed or refractory B-cell NHL

Study reports new insight into, target for Krabbe disease

BAL-101553 treatment associated with inhibition of CSLC-mediated tumor angiogenesis in vivo

Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo

FABP4 as a novel biochemical marker in diabetic ketoacidosis in children

TRPC4AP identified as gene biomarker candidate in thyroid dysgenesis

FDA authorizes first-in-human clinical trial of AZD-0466

First patient dosed in phase IIb ICONA study of icosabutate

Immunicum presents complete topline data from phase II MERECA study

Immutep announces positive interim data from TACTI-002 phase II study

GlaxoSmithKline and ViiV Healthcare patent new compounds for HIV

Zeno Royalties & Milestones presents WEE1hu inhibitors

Amgen identifies Mcl-1 inhibitors

Pliant Therapeutics describes integrin alphavbeta6 antagonists

New TYK2 inhibitors detailed in AbbVie patent

FDA approves Jynneos for prevention of smallpox and monkeypox disease in adults

Clinical phase IIa data on RNS-60 for multiple sclerosis presented

NIDA award to support Ensysce's development of opioid use disorder product

Phase II study of ganaxolone in refractory status epilepticus meets primary endpoint

Galmed initiates phase III/IV study of aramchol in patients with NASH and fibrosis

Curevo reports preliminary phase I data on shingles vaccine candidate CRV-101

European Commission approves Trogarzo for HIV-1

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
First-in-class non-β-lactam targeting AMR gram-negative pathogens
BioWorld Science
Antimicrobial resistance (AMR) is increasingly compromising the effectiveness of essential antibiotics, resulting in higher global mortality and morbidity rates....